ESC Premium Access

Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents

Congress Presentation

About the speaker

Miss Laura Kerkmeijer

Isala Clinics, Zwolle (Netherlands (The))
0 follower

26 more presentations in this session

Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry

Speaker: Doctor G. Gallone (Turin, IT)

Thumbnail

Long term clinical outcome of a novel sirolimus-eluting coronary stent in patients with acute myocardial infarction

Speaker: Doctor S. Dani (Ahmedabad, IN)

Thumbnail

Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

Speaker: Doctor H. Matsuda (Nagoya, JP)

Thumbnail

Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

Speaker: Doctor I. Menown (Craigavon, GB)

Thumbnail

Long-term outcomes after percutaneous coronary intervention with biodegradable polymer drug-eluting stent versus second-generation durable polymer drug-eluting stent: evidence from a meta-analysis

Speaker: Professor K. Cha (Pusan, KR)

Thumbnail

Access the full session

Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

Speakers: Miss L. Kerkmeijer, Doctor G. Gallone, Doctor S. Dani, Doctor H. Matsuda, Doctor I. Menown...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations